These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33706697)

  • 1. Beta-trace protein as a potential biomarker of residual renal function in patients undergoing peritoneal dialysis.
    Schwab S; Kleine CE; Bös D; Bohmann S; Strassburg CP; Lutz P; Woitas RP
    BMC Nephrol; 2021 Mar; 22(1):87. PubMed ID: 33706697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of residual renal function using beta-trace protein: Impact of dialysis procedures.
    Bargnoux AS; Buthiau D; Morena M; Rodriguez A; Noguera-Gonzalez ME; Gilbert O; Le Quintrec M; Kuster N; Cristol JP
    Artif Organs; 2020 Jun; 44(6):647-654. PubMed ID: 31951029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time.
    van Craenenbroeck AH; Bragfors-Helin AC; Qureshi AR; Lindholm B; Sjöberg B; Anderstam B; Heimburger O; Stenvinkel P; Bárány P
    Kidney Blood Press Res; 2017; 42(5):877-885. PubMed ID: 29161688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients.
    Gerhardt T; Pöge U; Stoffel-Wagner B; Klein B; Klehr HU; Sauerbruch T; Woitas RP
    Nephrol Dial Transplant; 2008 Jan; 23(1):309-14. PubMed ID: 17717031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of serum beta-trace protein as a tool for estimating residual kidney function in peritoneal dialysis patients.
    See YP; Htay H; Teixeira-Pinto A; Pascoe EM; Hawley C; Cho Y; Zhao E; Johnson DW
    Perit Dial Int; 2021 Mar; 41(2):226-235. PubMed ID: 32815791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating residual kidney function in dialysis patients without urine collection.
    Shafi T; Michels WM; Levey AS; Inker LA; Dekker FW; Krediet RT; Hoekstra T; Schwartz GJ; Eckfeldt JH; Coresh J
    Kidney Int; 2016 May; 89(5):1099-1110. PubMed ID: 26924062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure.
    Manzano-Fernández S; Januzzi JL; Boronat-Garcia M; Bonaque-González JC; Truong QA; Pastor-Pérez FJ; Muñoz-Esparza C; Pastor P; Albaladejo-Otón MD; Casas T; Valdés M; Pascual-Figal DA
    J Am Coll Cardiol; 2011 Feb; 57(7):849-58. PubMed ID: 21310322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Foster MC; Coresh J; Hsu CY; Xie D; Levey AS; Nelson RG; Eckfeldt JH; Vasan RS; Kimmel PL; Schelling J; Simonson M; Sondheimer JH; Anderson AH; Akkina S; Feldman HI; Kusek JW; Ojo AO; Inker LA;
    Am J Kidney Dis; 2016 Jul; 68(1):68-76. PubMed ID: 26948990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the diagnostic value of rescaled β-trace protein in combination with serum creatinine and serum cystatin C in older adults.
    Pottel H; Schaeffner E; Ebert N
    Clin Chim Acta; 2018 May; 480():206-213. PubMed ID: 29476732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is beta-trace protein an alternative marker of glomerular filtration rate in liver transplant recipients?
    Gerhardt T; Pöge U; Stoffel-Wagner B; Palmedo H; Sauerbruch T; Woitas RP
    Liver Int; 2011 Oct; 31(9):1345-51. PubMed ID: 21745310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Variability of Estimated GFR and Albuminuria in CKD.
    Waikar SS; Rebholz CM; Zheng Z; Hurwitz S; Hsu CY; Feldman HI; Xie D; Liu KD; Mifflin TE; Eckfeldt JH; Kimmel PL; Vasan RS; Bonventre JV; Inker LA; Coresh J;
    Am J Kidney Dis; 2018 Oct; 72(4):538-546. PubMed ID: 30031564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.
    Manzano-Fernández S; López-Cuenca A; Januzzi JL; Parra-Pallares S; Mateo-Martínez A; Sánchez-Martínez M; Pérez-Berbel P; Orenes-Piñero E; Romero-Aniorte AI; Avilés-Plaza F; Valdés-Chavarri M; Marín F
    Am J Cardiol; 2012 Nov; 110(9):1240-8. PubMed ID: 22818840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease.
    Spanaus KS; Kollerits B; Ritz E; Hersberger M; Kronenberg F; von Eckardstein A;
    Clin Chem; 2010 May; 56(5):740-9. PubMed ID: 20224047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of GFR in children using rescaled beta-trace protein.
    den Bakker E; Gemke R; Pottel H; van Wijk JAE; Hubeek I; Stoffel-Wagner B; Bökenkamp A
    Clin Chim Acta; 2018 Nov; 486():259-264. PubMed ID: 30121167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum beta-trace protein (BTP) measurement in the prediction of glomerular filtration rate. Comparison with serum cystatin C.
    Solichova P; Novackova L; Ochmanova R; Stejskal D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Jul; 150(1):83-4. PubMed ID: 16936905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective cohort studies of beta-trace protein and mortality in haemodialysis patients and patients undergoing coronary angiography.
    Enko D; Meinitzer A; Scharnagl H; Stojakovic T; Kleber ME; Delgado GE; Zelzer S; Drechsler C; Krämer BK; Wanner C; März W; Woitas RP
    Nephrol Dial Transplant; 2018 Nov; 33(11):1984-1991. PubMed ID: 29474602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum β-trace protein and risk of mortality in incident hemodialysis patients.
    Shafi T; Parekh RS; Jaar BG; Plantinga LC; Oberai PC; Eckfeldt JH; Levey AS; Powe NR; Coresh J
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1435-45. PubMed ID: 22745274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminal agrin fragment (CAF) as a serum biomarker for residual renal function in peritoneal dialysis patients.
    Steubl D; Hettwer S; Dahinden P; Luppa P; Rondak IC; Regenbogen C; Stock KF; Renders L; Heemann U; Roos M
    Int Urol Nephrol; 2015 Feb; 47(2):391-6. PubMed ID: 25352149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
    Donadio C; Tognotti D; Caponi L; Paolicchi A
    BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
    Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
    Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.